Letter to HHS and FDA: Forced Switch Share page: We understand that FDA is considering a switch of a second generation antihistamine, from prescription to OTC status, over the objections of the company. CHPA opposes a policy to force switch over the objections of the drug sponsor. Download Document Issues: OTC Medicines Rx-to-OTC Switch Related Posts Press Releases and Statements CHPA Response to Study Examining Prescription Acid Reflux Drugs Following Inaccurate Media Reports: Apr 25, 2024 Articles Polibrief: Consumer Data Privacy: State Efforts to Preserve Privacy Apr 16, 2024 Press Releases and Statements Self-Care Industry Representatives Participate in Capitol Hill Briefing Highlighting Legislative Priorities Apr 11, 2024